A new study finds more children and teens are taking alternative meds like melatonin and probiotics despite limited evidence they are safe or effective.

AI analysis of social media posts reveals potential side effects of GLP-1 meds that researchers say may not be fully captured in clinical trials.

A large, new evidence review finds intermittent fasting may not help overweight or obese patients loose a significant amount of weight or improve their quality of life.

A large, new study finds adults who use GLP-1 medications face higher odds of a common form of hair shedding, as well as male or female pattern baldness.

A new study finds when people start taking GLP-1 medications, spending at grocery stores and restaurants changes.

A new study finds children and teens with obesity or diabetes who take GLP-1 weight-loss medications experience significant improvements in many cardiometabolic risk factors, but long-term safety questions remain.

A new study finds women with obesity who lose weight before IVF have increased odds of getting pregnant, especially through natural conception.

In a new study, people lost twice as much weight on a diet with minimally processed foods compared to one with ultra-processed foods.

People who quit taking anti-obesity meds, including popular GLP-1 receptor agonists, may regain a significant amount of weight after eight weeks, a new study finds.

Patients with obesity who take GLP-1 receptor agonists in real-world settings lose significantly less weight than participants in randomized clinical trials, according to new research.